Skip to main content
. 2020 Jan 2;12(1):38. doi: 10.3390/pharmaceutics12010038

Scheme 1.

Scheme 1

Scheme 1

Synthetic scheme of (A) MPA and (B) assembly process of disulfide cross-linked nanoparticles.